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Background: FGF signaling plays numerous roles during organogenesis of the embryonic gut tube. Mouse explant
studies suggest that different thresholds of FGF signaling from the cardiogenic mesoderm induce lung, liver, and
pancreas lineages from the ventral foregut progenitor cells. The mechanisms that regulate FGF dose in vivo are
unknown. Here we use Xenopus embryos to examine the hypothesis that a prolonged duration of FGF signaling
from the mesoderm is required to induce foregut organs.
Results: We show that both mesoderm and FGF signaling are required for liver and lung development in Xenopus;
formally demonstrating that this important step in organ induction is conserved with other vertebrate species.
Prolonged contact with the mesoderm and persistent FGF signaling through both MEK and PI3K over an extended
period of time are required for liver and lung specification. Inhibition of FGF signaling results in reduced liver and
lung development, with a modest expansion of the pancreas/duodenum progenitor domain. Hyper-activation of
FGF signaling has the opposite effect expanding liver and lung gene expression and repressing pancreatic markers.
We show that FGF signaling is cell autonomously required in the endoderm and that a dominant negative FGF
receptor decreases the ability of ventral foregut progenitor cells to contribute to the lung and liver buds.
Conclusions: These results suggest that the liver and lungs are specified at progressively later times in
development requiring mesoderm contact for different lengths of time. Our data suggest that this is achieved at
least in part through prolonged FGF signaling. In addition to providing a foundation for further mechanistic studies
on foregut organogenesis using the experimental advantages of the Xenopus system, these data have implications
for the directed differentiation of stem cells into foregut lineages.
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In the Fibroblast Growth Factor (FGF) signaling path-
way, secreted ligands bind to transmembrane tyrosine
kinase FGF receptors causing dimerization and activa-
tion of a number of intracellular signal transduction cas-
cades including the mitogen-activated protein kinase
(MEK) and phosphoinositide 3-kinase (PI3K), which
phosphorylate Erk and Akt, respectively [1]. FGF signals
regulate cellular differentiation, proliferation, and sur-
vival in many contexts and studies in mice, chick, and
zebrafish have shown that FGF mediated mesenchymal-
epithelial interactions play numerous roles in the devel-
oping gut tube [2-4]. During gastrulation, FGF signaling* Correspondence: aaron.zorn@cchmc.org
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reproduction in any medium, provided the orpatterns the primitive gut tube by promoting posterior
over anterior cell fate in the endoderm [5]. Then only
hours later, FGF signals from the anterior lateral plate
and cardiac mesoderm segregate the pancreas, liver, and
lung lineages from a pool of ventral foregut progenitor
cells [6-12]. Recent studies in zebrafish suggest that FGF
signaling acts in part by restricting hepatic competence
of the endoderm along the anterior-posterior (A-P) axis
[13,14]. Additionally, FGFs are important for the out-
growth and morphogenesis of many organ buds during
fetal development; for instance mesenchymal FGF10
controls lung branching [15,16], pancreas proliferation
and growth [17,18], stomach morphogenesis [19], and
hepatopancreatic fate [20]. Considering these multiple
context-dependent activities, it is likely that a better
understanding of the precise temporal roles of FGF sig-
naling during endoderm organogenesis will informLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cells in vitro [2,21].
In this study we investigated the role that FGF signal-
ing plays in the specification of foregut organs in Xen-
opus embryos. In zebrafish and chick, FGF signals (along
with BMP and Wnt) have been shown to be essential for
hepatic specification [6,7]. Additionally, in vitro studies
using mouse embryo foregut explant cultures from 0–7
somite-stages (ss) of development have suggested that
FGF signals from the cardiac and lateral plate mesoderm
regulate the induction of the pancreas, liver, and lungs in
a dose-dependent manner [8,10]. Little or no FGF signal-
ing is required for ventral endodermal explants from
early somite-stage mouse embryos to turn on the pan-
creas marker Pdx1, whereas explants cultured with car-
diac mesoderm or recombinant FGF2 express the liver
marker Albumin [12] and higher FGF doses stimulate ex-
pression of the thyroid/lung marker Nkx2.1 [8]. Similar
dose-responsive FGF effects have been observed during
the differentiation of human ES cells to foregut lineages
[22,23]. Downstream of FGF receptor signaling, it has
been shown that in mouse embryos the MEK branch of
the FGF pathway is necessary for liver Albumin and
Alpha-fetoprotein expression, while the PI3K branch pro-
motes hepatoblast proliferation [9]. These data have led
to a model of foregut organ development where different
doses of FGF specify the different foregut lineages: very
low or absent FGF levels are required for pancreas, inter-
mediate FGF levels promote liver, and high FGF levels
are required for lung. The mechanisms by which differ-
ent thresholds of FGF are achieved in vivo are unknown,
in part because mouse embryos are difficult to manipu-
late at these early stages in development.
Xenopus embryos have increasingly proven to be a
valuable model to study the mechanisms of organogen-
esis [24,25]. Horb and Slack have shown that signals
from the mesoderm between stages NF15 (0 ss) to NF42
(organ bud stage) are required for Xenopus endodermal
explants to become regionally specified into anterior and
posterior organ lineages [26]. Consistent with a con-
served role for FGF signaling in Xenopus foregut organ
induction, multiple FGF ligands and receptors are
expressed in the Xenopus foregut mesenchyme and
endoderm between stages NF15-42 [27] . Moreover, FGF
signaling is necessary for the induction of liver gene ex-
pression in cultured ectodermal explants in vitro [28]
and Akt signaling is required for later pancreas and
stomach progenitor cell survival [29].
Despite these suggestive data, the role of FGF signaling
in Xenopus foregut organ specification in vivo has not
formally been determined. In this study, we show that:
1. The pancreas, liver and lung are specified at
progressively later times in Xenopus development,and that the liver and lungs require progressively
longer mesoderm contact;
2. FGF signaling is required for lung and liver
specification in vivo and this is, at least in part, a cell
autonomous requirement in the endoderm;
3. Foregut endoderm in which FGF signaling is
experimentally blocked appears to remain in a
progenitor-like state;
4. Ectopic activation of the FGF pathway expands liver
and lung development, and represses pancreatic fate;
5. The high levels of FGF necessary for lung and liver
induction appear to be achieved through FGF
signaling over an extended period of time via both
the MEK and PI3K pathways.
This temporal requirement for FGF signaling in fore-
gut lineage segregation provides the foundation for fu-
ture mechanistic studies in Xenopus, and may impact




Xenopus laevis embryos were cultured as previously
described [30]. All animal experiments complied with
the “Animal Research: Reporting in vivo Experiments”
(ARRIVE) guidelines and were approved by the Cincin-
nati Children’s Research Foundation IACUC committee
(protocol #0B12097). For microdissection, ventral
explants were dissected from embryos using eyelash
blades and hair loops. At the indicated developmental
time half of the explants had the mesoderm separated
using hair loops in 5 units/ml Dispase (BD Biosciences)
for 10–15 min (Figure 1A). Endoderm explants (+meso
and –meso) were then cultured in 0.5xMBS to Stage 37
for analysis. Synthetic RNA for microinjection was tran-
scribed using the mMessage Kits (Ambion) and purified
on Microspin-6 columns (BioRad). The following plas-
mids were used for mRNA synthesis (enzymes used to
linearize DNA templates, RNA polymerase): pRN3 GFP
(SfiI, T3); pCS2 + β-gal (NotI, Sp6); dnFGFR (pxFD/
XSS) (EcoRI, SP6); caFGFR (iFGFR1) (Not1, SP6).
Embryos with clear dorsal-ventral pigment were selected
for injections into the bottom of dorsal-vegetal blasto-
meres at the 4-8-cell stage to target large regions of the
foregut mesendoderm and into the D2.1 cells at the 16-
cell stage to target foregut endoderm avoiding the meso-
derm. Lineage labels were used to confirm the correct
targeting. Cell soluble inhibitors were dissolved in
DMSO and added to the media at the following working
concentrations: PD173074 (300 μM; TOCRIS), U0126
(Cell Signaling, 300 μM), LY294003 (Cell Signaling,
40 μM), and SU5402 (10 μM with 0.1 M ATP). B/B
Homodimerizer (Clontech) was dissolved in 100%
Figure 1 Foregut organ specification requires prolonged contact with the cardiac-lateral plate mesoderm. (A) Diagram of the
experimental design. Ventral explants were cultured with (+Meso) or without mesoderm (−Meso) during the indicated time points and assayed
by in situ hybridization at stage NF37. (B) Summary of experimental results showing the percentage of explants with mesoderm removed at
different times expressing liver (nr1h5), lung/thyroid (nkx2.1) and pancreas (pdx1 or ptf1a) markers at stage NF37, n > 20 explants for each
condition and each probe. (C) Representative explants cultured from stage NF16 to NF37 with or without mesoderm and corresponding whole
embryo controls assayed by in situ hybridization with the indicated markers. Endodermal (gjb1) or mesodermal (foxf1 and tnni3) specific markers
demonstrated clean separation of the tissues.
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Explants were cultured in 100 ng/ml of human recom-
binant FGF2 (Invitrogen) in 0.5XMBS+ 0.1%BSA.
In situ hybridization
In situ hybridizations were performed as previously
described [31] using the following probes: nr1h5 (for-
mally for1, Xenbase.org) [32], pdx1 [33], ptf1α [34],
nkx2.1 [35], tnni3 (formally cardiac-troponin, Xenbase.
org) [36], foxf1 [37], gjb1 [38], hhex [39], nkx2.5 [40],
hnf4α [41]. Image-J software was used to measure the
average size of the hhex and pdx1 expression domains
+/− S.D. in injected and control sibling embryos.
Immunostaining and Western blot analysis
For Western blots, five embryos per sample were lysed
in a TLB buffer (1% Triton X 100, 25 mM Tris pH 7.4,
150 mM NaCl, 2 mM Na3VO4, 2.5 mM NaF and 25 mM
B-glycerophosphate) with protease and phosphatase
inhibitors each diluted 1:100: phosphatase inhibitor
cocktail II (Sigma), PhosSTOP (Roche), protease inhibi-
tor cocktail (Sigma). Samples were run on a 10% poly-
acrylamide gel and transferred to an Immobilon
membrane (Millipore). The membrane was incubatedwith the following antibodies: mouse anti-dpErk1/2
(1:250, Sigma), rabbit anti-Erk2 (1:1000, Cell Signaling),
rabbit anti-pAkt (1:1000, Cell Signaling), and rabbit anti-
AKT (1:1000, Cell Signaling) and analyzed using the
ECL Plus system (GE Healthcare) and a FUJIFILM LAS-
4000 luminescent analyzer.
For immunofluorescence, Xenopus embryos were fixed
in MEMFA for 2 h at RT, bisected with a razor blade,
and stored in Dent’s fixative (80%MetOH+20%DMSO).
For confocal analysis, the embryo pieces were rehydrated
though a methanol series, blocked with BBT (PBS, 1%
bovine albumin, 0.1%Triton) for 2 h and BBT with 5%
serum for 1 h, incubated with primary antibody over-
night at 4°, washed in PBS 0.2%Triton, incubated with
secondary antibody overnight at 4°, washed again, dehy-
drated in methanol, then cleared with a Benzyl Benzoate
and Benzyl Alcohol mix (2:1). For immunofluorescence,
the following antibodies were used, primary: rabbit anti-
dpErk1/2 (1:300, Cell Signaling), mouse anti-GFP (1:300,
Clonetech), rabbit anti-phospho-Histone H3 (1:300, Cell
Signaling), and rabbit anti-active-Caspase 3 (1:300, Cell
Signaling); and secondary antibodies: anti-rabbit-CY5
(1:500, Jackson), anti-mouse-CY2 (1:500, Jackson) or
goat anti-rabbit-AP (1:5000, Jackson).
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Pancreas, liver, and lung are specified at progressively
later times in development through prolonged
interactions with cardiac-lateral plate mesoderm
As a first step in characterizing the potential role of
FGFs in Xenopus foregut organ induction we carefully
examined when during development different foregut
lineages were specified. Horb and Slack have previously
demonstrated in Xenopus that mesodermal signals be-
tween stages NF15 to NF42 are required in order for the
endoderm to become regionally specified and express
pancreas, liver, and intestinal markers at stage NF42
[26]. In order to determine whether distinct lineages are
specified at different times, we performed a series of
microdissection experiments isolating ventral explants
and removing the ventral cardiac/lateral plate mesoderm
from the endoderm at different times in development
(Figure 1A). Explants were cultured until stage NF37
(~40 ss) and analyzed by in situ hybridization for expres-
sion of early lineage markers of the pancreas (pdx1 and
pft1a; [33,42]), liver (nr1h5; [32]) and lung/thyroid
(nkx2.1; [35]) (Figure 1B, C). As controls to verify effect-
ive separation of the endoderm from mesoderm tissue,
we examined the expression of the pan-endodermal
marker gjb1 [38], the lateral plate mesoderm marker
foxf1 [37], and the cardiac mesoderm marker tnni3 [36]
(Figure 1C). These controls demonstrated that our
method of removing the mesoderm by dispase treatment
and manual pealing off the tissue with hairloops effect-
ively produced endoderm explants without foxf1+ and
tnni3+ mesoderm.
These experiments showed that the expression of early
pancreas, liver, or lung markers in the endoderm
required mesoderm contact for different periods of time.
Interestingly, we observed the pancreas-duodenum mar-
ker pdx1 was expressed in explants >75% of the time re-
gardless of when the mesoderm was removed between
stages NF16-35 (Figure 1B,C). We obtained similar
results with another pancreas marker ptf1a, suggesting
that as early as stage NF16 the endoderm has received
sufficient signals to activate expression of pancreatic
progenitor markers by stage NF35. In contrast, expres-
sion of the lung and liver markers required longer dura-
tions of mesodermal contact. Expression of the liver
marker nr1h5 required mesoderm contact until stages
NF25-28, after which point the mesoderm was no longer
required (Figure 1B,C). In contrast, nkx2.1 expression
was not induced in endoderm explants unless mesoderm
was kept in contact throughout stage NF35 (36 ss;
Figure 1B,C). In explants cultured with mesoderm
through stage NF35, the nkx2.1+ tissue was observed in
two discreet domains immediately dorsal-posterior to
the heart, indicative of lung tissue. We conclude that the
pancreas, liver, and lungs are specified at progressivelylater times in development in a caudal-to-rostral pro-
gression along the A-P axis. The most caudal tissue the
pancreas is specified first, followed by liver, which
requires mesoderm contact until NF31 and then the
most rostral organ the lung is specified last requiring
mesoderm contact up to NF35.
FGF signaling is active in the Xenopus foregut endoderm
during organ induction
Our tissue separation experiments show that complete
organ induction requires mesodermal contact between
stages NF16-35. A survey of the literature indicates that
many FGF ligands (FGF1-4,6,8,9,14,19,22,23) and recep-
tors are expressed in the Xenopus foregut region during
this time in development [27,43]. To investigate if and
when the Xenopus ventral foregut endoderm is respond-
ing to FGF signaling we examined di-phosphorylated
Erk1/2 (pErk) immunostaining as a read-out of active
FGF/MEK signaling. In the gastrula embryo, pErk was
not detected in the endoderm and was restricted to the
involuting mesoderm, as previously described [44]. We
first detected a low level of pErk in the anterior mesen-
doderm at stage NF15 as it migrates to its final position
in the ventral foregut (Figure 2A). Between stages NF19-
28 robust pErk was present in the ventral foregut pro-
genitors and in the adjacent cardiac and lateral plate
mesoderm (Figure 2B-D). By stage NF35 when lung and
liver specification markers begin to be expressed pErk is
detected in the thickening hepatic epithelium and the
nascent lung buds, as well as in the heart and lateral
plate mesoderm (Figure 2E, F). In stage NF42 gut tubes,
we detected pErk in the liver and pancreatic buds, stom-
ach, and the distal tips of the lung buds consistent with
a role for FGF signaling during organ bud outgrowth
(Figure 2G, H). This data reveals that between stages
NF15-35, the period when mesoderm is required for
liver and lung specification, the endoderm is experien-
cing active pErk signaling.
FGF signaling induces lung and liver, and represses early
pancreas fate
Multiple FGF ligands and receptors are expressed in the
Xenopus foregut during organ induction [27,43]. In
order to inhibit all FGF signaling in the foregut endo-
derm, we cultured embryos from stage NF18 to NF35
with a small molecule inhibitor PD173074 (FGFRi),
which blocks FGF receptor activity [45] and analy-
zed them for mature liver (nr1h5), pancreas (ptf1α),
lung (nkx2.1), and heart (tnni3) markers (Figure 3A).
Western blot analysis confirmed that FGFRi treatment
dramatically reduced FGF/pErk and FGF/pAkt activity
(Figure 3B) and blocked expression of the FGF target
gene spry2 (Figure 3A). FGFRi treatment resulted in a
dramatic reduction or complete loss of liver (97% of
Figure 2 FGF signaling is active in the foregut endoderm during organ induction. Confocal immunostaining of bisected Xenopus embryos
show active FGF-MEK signaling with di-phospho ERK1/2 (pErk) (white) in the developing foregut tissue at the indicated stages (anterior left,
ventral down). Images are 10X magnification with independent scans of the boxed regions at 20X magnification. (A) Stage NF15 embryos show a
low level of FGF signaling in the migrating anterior mesendoderm (ame). (B) Stage NF19, (C) NF23 and (D) NF28 show pErk staining in the
ventral foregut endoderm (fg) as well as the underlying cardiac mesoderm (cm). The dashed yellow line indicates the boundary between the
endoderm and mesoderm. (E) Mid-sagittal and (F) transverse optical sections of stage NF35 embryos show pErk staining in the liver epithelium
(lv), heart (ht) and nascent lung buds (lu) and lateral plate mesoderm (lpm). (G and H) Stage NF42 gut tubes show pErk in liver bud (lv), gal
bladder (gb), dorsal (dp) and ventral pancreatic buds (vp), the stomach (st) and the distal tips of the lung buds (lu). (I) Stage NF23 control
embryos with no primary antibody.
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sion (Figure 3 A,C). We did not observe any obvious im-
pact on nkx2.1 expression in the thyroid region. This
FGF requirement in lung development is similar to that
recently described by Wang et al. [46]. In contrast, ex-
pression of the early pancreas marker ptf1α was only
reduced in 37% (n = 56) of the FGF-inhibited embryos,
suggesting that pancreas specification requires little if
any FGF signaling during these stages (Figure 3 A,C).
Treatment with a second independent FGF receptor
inhibitor SU5402, or injection of RNA encoding a dom-
inant negative FGF receptor (dnFGFR) into the pre-
sumptive foregut mesendoderm at the 4–8 cell stage
[47] caused a similar loss of liver and lung gene expres-
sion at stage NF35, with little if any impact on the pan-
creas gene expression relative to controls (Figure 3C,
data not shown).
To test whether FGF signaling was sufficient to induce
lung and liver fate we cultured foregut endoderm
explants lacking mesoderm with recombinant FGF2, but
this was not sufficient to induce nr1h5 or nkx2.1 expres-
sion (Additional file 1: Figure S1). This suggests thatother mesodermal signals in additional to FGFs are also
required, the most likely candidate being BMPs, which
we have recently shown is also required to maintain
foregut progenitors [48]. To overcome this complication,
we injected the presumptive foregut mesendoderm with
a drug inducible FGFR1 construct (caFGFR) [49]. When
injected embryos were treated from stage NF18 to NF35
with the drug “B/B-Homodimerizer” (Clontech) this
causes receptor clustering and ligand-independent FGFR
signaling as measured by increased pErk levels
(Figure 3B). Activation of the caFGFR caused an expan-
sion of liver (nr1h5) and lung (nkx2.1) expression
domains in 30% and 75% of the embryos respectively
(Figure 3A,C). In contrast, the pancreas marker ptf1α
was reduced or absent in 86% of the activated caFGFR
embryos (Figure 3A,C).
We next wanted to determine what became of the pre-
sumptive liver and lung foregut endoderm when FGF
signaling was blocked. One possibility was that it
adopted a more posterior fate, but analysis of FGFRi
embryos with intestinal markers indicated that this was
not the case (data not shown). We next tested whether
Figure 3 FGF signaling is required for lung and liver specification at the expense of pancreas. (A) In situ hybridization with the indicated
probes in control, FGF-inhibited or FGF-activated embryos. Embryos were cultured in DMSO or PD173074 (FGFRi) from NF18 to NF35 to inhibit
FGF signaling. Control uninjected or embryos injected with RNA encoding an inducible FGF receptor (caFGFR; 20 pg) into vegetal blastomeres at
the 4/8-cell stage, were treated with the homodimerizing drug from NF18 to NF35 to activate FGF signaling. Yellow arrows indicate normal
expression, red arrows absent expression, blue arrows ectopic expression; yellow dash outlines expression boundaries. p; pancreas, lv; liver, lu;
lung, th; thyroid, h; heart. (B) Western blot analysis of pErk, total Erk, pAkt and total Akt in embryos cultured in either PD173074 (FGFRi) or DMSO
from stage NF18 to NF35 (in triplicate). Western blot analysis of embryos injected with caFGFR(+) and treated from NF18 to NF35 with B/B
Homodimerizer show increased FGF/pErk signaling compared to uninjected controls at Stage NF 23 (lanes1 + 2) and Stage NF 35 (lanes3 + 4). (C)
Summary of gene expression in FGF-inhibited (FGFRi or dnFGFR; 3 ng) and FGF-activated (caFGFR; 20 pg) embryos. Controls include DMSO
treated, β-gal injected and uninjected B/B dimerizing drug treated, none of which had an obvious impact on gene expression. (D) Quantification
of average hhex and pdx1 expression areas in control and FGF-manipulated embryos. ImageJ software was used to measure the expression area
with the average expression area of controls set to 1. Averages are based on n > 13 embryos for each condition and marker from at least two
independent experiments, standard deviation and significance based on t-test (**p < 0.004).
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progenitor identity prior to lineage segregation. We
therefore examined the expression of hhex, which is ini-
tially expressed throughout the foregut endoderm, but
then becomes restricted to the liver and thyroid as
organ induction proceeds [39]. However, in embryos
treated with the FGFRi from stage NF15 to NF23, or
embryos injected with dnFGFR RNA we found that
hhex expression was largely unaffected at stage NF23
(Additional file 2: Figure S2A), indicating that FGF sig-
naling is not required to maintain the foregut progeni-
tors at this stage. In addition when we examined hhex
expression in embryos treated with FGFRi from NF18-
35; hhex was still present in most embryos, although
the size of the expression domain was significantly
reduced (Figure 3A,C,D). This result was in contrast to
the liver specification marker nr1h5, which was absent
in most FGFRi embryos, suggesting that when FGF sig-
naling is inhibited the foregut cells are blocked in a
progenitor-like state.
We also closely examined pdx1 expression because
mouse explant experiments suggest that in the absence
of cardiac mesoderm or absence of FGF, the foregut
adopts a pdx1+ pancreatic/duodenal fate rather than
liver fate [12]. In Xenopus pdx1 is expressed in the pan-
creatic/duodenal progenitors prior to the expression of
ptf1a. FGFRi treatment caused a modest, but significant
expansion in the size of the pdx1+ expression domain
(Figure 3A,C,D). Examination of hhex and pdx1 in
embryos where FGF signaling was ectopically activated
by the caFGFR revealed the opposite phenotype with a
significant expansion of hhex and a reduced or absent
pdx1 expression domain (Figure 3A,C,D).
Together these results indicate that FGF signaling is
required for hepatic specification from hhex + progeni-
tors. The data further suggests that similar to what has
been reported in mice, FGF regulates the choice of Xen-
opus endoderm progenitors cells to adopt liver versus
pancreas fates.
FGF signaling is required autonomously in the endoderm
The Xenopus lateral plate and pre-cardiac mesoderm is
also patterned by FGF signaling [50-52]. Since the car-
diac mesoderm, in particular, is implicated in foregut
organ induction it was possible that the effects on endo-
derm gene expression we observed in FGF-inhibited
embryos were secondary to mesodermal changes. We
therefore examined the expression of the cardiac pro-
genitor marker nkx2.5 at stage NF23 and the myocardial
differentiation marker tnni3 at stage NF35. Although
nkx2.5 and tnni3 expression were reduced in approxi-
mately 50% of FGF-inhibited embryos, both heart mar-
kers were almost always present (Figure 3A; Additional
file 2: Figures S2A and Additional file 3: Figure S3A).This suggested that impaired cardiac development was
unlikely to completely explain the loss of liver and lungs.
To directly test the cell-autonomous need for FGF
signaling in foregut endoderm progenitors, we injected
RNA encoding GFP along with dnFGFR or β-
galactosidase (β-gal) RNA into the D2.1 blastomeres at
the 16-cell stage, which targets the RNA to the foregut
endoderm, and avoids the mesoderm. Injection of the
dnFGFR into the mesoderm frequently causes gastrula-
tion defects [47] and we observed this in about 50% of
our 4-cell stage injections in Figure 3. In contrast the
foregut-targeted embryos gastrulated normally and the
lineage label showed that the anterior mesendoderm
migrated correctly to the ventral foregut position
(Figure 4A). Immunostaining of injected embryos con-
firmed that dnFGFR/GFP expressing cells lack robust
pErk activity at stage NF23 (Figure 4A). We then scored
isolated gut tubes at stage NF42 to determine which tis-
sues the lineage labeled cells had contributed.
The most severe phenotype in these experiments was
a complete loss of all discernable foregut organ buds,
which never occurred in controls (data not shown); con-
sistent with foregut endoderm requiring FGF signaling
to induce organ lineages. In gut tubes with mosaic ex-
pression of labeled cells, we found that control β-gal/
GFP cells contributed to the liver in 28% and the lung in
approximately 30% of embryos, whereas dnFGFR/GFP-
expressing cells only contributed to the liver in 11% and
the lung in 5% of embryos (Figure 4B, C). Importantly,
gfp positive cells were not detected in the cardiac meso-
derm, verifying that the RNA was specifically targeted to
the endoderm. This excludes the possibility that the
defects in liver and lung contribution were only sec-
ondary to cardiac defects and demonstrates a cell-
autonomous requirement for FGF signaling in the
endoderm. There was little difference in contribution of
control βgal or dnFGFR expressing cells to the intestine,
pancreatic buds, or stomach (Figure 4B, C), suggesting
that robust FGF signaling is not required for cells to
populate these tissues. We conclude that ventral foregut
endoderm progenitors that cannot receive an FGF signal
are less likely to contribute to lung and liver buds.
Prolonged FGF signaling is required for lung and liver
induction
In vitro mouse explant experiments using high doses of
recombinant FGF signaling induce Nkx2.1 expressing
lung tissue, whereas moderate doses of FGF induce
liver-specific gene expression [8]. To test whether Xen-
opus liver and lung fate exhibit a similar dose-dependent
need for FGF signaling in vivo we treated embryos with
different concentrations of the FGFRi from stages NF18
to NF35. This resulted in the expected dose-dependent
reduction in endogenous pErk (data not shown).
Figure 4 Inhibition of FGF signaling in Xenopus embryos. (A)
Confocal immunostaining of pErk (red) and a GFP lineage tracer
(green) in the foregut region of bisected stage NF23 Xenopus
embryos that were injected into the presumptive foregut endoderm
cells at the 16-cell stage with RNA encoding either β-gal (3 ng) and
GFP or dnFGFR (3 ng) and GFP. The β-gal/GFP injected embryos
show pErk in GPF + cells whereas in dnFGFR/GFP injected embryos
pErk is undetectable in GFP + foregut cells. (B) A representative
stage NF42 gut tube from βgal/GFP and dnFGFR/GFP injected
embryos assayed by in situ hybridization for gfp RNA to show
mosaic contribution of labeled cells to different organ buds. p;
pancreas, lv; liver, s; stomach, i; intestine. (C) Summary showing
percentage of organ buds containing labeled cells indicates a
decreased contribution to the lung and liver buds in dnFGFR
injected embryos (n = 120) compared to βgal controls (n = 70).
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exhibited a similar dose responsive reduction in expres-
sion (Additional file 2: Figure S2B), suggesting that the
level of FGFR activity per se does not regulate lung ver-
sus liver fate in Xenopus. We therefore considered the
alternative hypothesis that FGF signaling might induce
the liver and lungs at different times in development. Totest these temporal requirements for FGF signaling, we
treated embryos for different time periods with the FGF
receptor inhibitor (Figure 5A) and scored liver and lung
specification at stage NF35 (Figure 5B).
We found that inhibition of FGF signaling for shorter
periods of time (NF18-23, NF23-28, and NF23-25) all
resulted in a reduction in liver and lung marker
expression, which was less dramatic than when FGF
signaling was inhibited for the entire NF18-35 period
(Figure 5B). We noticed that the level of reduction in
nkx2.1-expressing lung tissue was similar in the various
intermediate treatments, whereas the reduction in liver
gene expression was more dramatic at earlier time
points. These results are consistent with the tissue sep-
aration experiments (Figure 1), which indicate that the
liver is specified earlier than the lung. Cardiac tnni3 ex-
pression was mildly reduced across FGF inhibition
treatments, with the long and early periods showing
the most effects (Figure 5B, Additional file 3: Figure
S3A) [50]. These data suggest that prolonged FGF sig-
naling throughout the organ induction period is neces-
sary to specify both liver and lung, and that lung fate
requires the longest duration of active FGF signaling.
PI3K and MEK branches both contribute to lung and liver
development
There is evidence from mouse foregut explants that dif-
ferent branches of FGF signaling play distinct roles in
foregut development, with MEK being required for liver
gene expression whist the PI3K branch regulates prolif-
eration [9]. To determine if a distinct FGF signaling
pathways were required for foregut lineages in Xenopus,
we cultured the embryos in either LY294002 (a PI3K in-
hibitor) or U0126 (a MEK1/2 inhibitor) [53,54] from
stage NF18 to NF35 and analyzed the foregut organ
lineage markers. Western blot analysis confirmed that
PI3K inhibition (PI3Ki) resulted in a significant decrease
in phospho-Akt (pAkt), whereas MEK1/2 inhibition
(MEKi) resulted in a significant decrease in pErk com-
pared to vehicle treated controls (Figure 6A). PI3Ki and
MEKi treatments caused reduced or absent liver expres-
sion in 62% or 34% of the embryos respectively, which
was not as dramatic as the reductions caused by FGFRi
treatment (Figure 6B,C), suggesting that both the PI3K
and MEK branches are both involved in Xenopus hepatic
induction. Nkx2.1 expression was reduced or absent in
83% of PI3Ki embryos, similar to FGFRi, but in only 45%
of MEKi embryos, suggesting prolonged PI3K activity is
particularly important in lung specification (Figure 6B,
C). If we removed the FGFRi at NF35 and isolated em-
bryonic gut tubes at stage NF42, 46% of the lung and
75% of the liver buds were dramatically reduced in size,
while the pancreas, stomach, and intestine were largely
unaffected (Figure 6B). In comparison, the PI3Ki or
Figure 5 Prolonged FGF signaling is required for lung and liver induction. (A) Experimental design showing the time-course of FGFRi
treatment. (B) Embryos treated with DMSO or FGFRi at the indicated stages were assayed at stage NF35 by in situ hybridization for markers of
liver (nr1h5), lung (nkx2.1), and heart (tnni3). Representative examples are shown and the graph summarizes the % of embryos with normal, weak,
or severely reduced/absent expression.
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gut organ bud size at NF42, which were not as dramatic
as those seen with the FGFRi (Figure 6B). We also tested
whether PI3K or MEK were required at different times
in development by treating embryos for shorter time
periods. Similar to the results with the FGFRi, treatment
with either MEKi or PI3Ki for a variety of shorter dura-
tions between stage NF18-35 all resulted in a modest re-
duction in lung and liver gene expression which was less
severe than the FGFRi treatment over the similar period;
and caused little change in pancreas specification con-
sistent with the FGFRi data (Additional file 3: Figure
S3A). This data suggests there is not a specific time
when the PI3K or MEK branches act, but support a dur-
ation model where both branches are necessary over a
prolonged period (NF18-35).
The fact that PI3Ki and MEKi both resulted in moder-
ate phenotypes less severe than FGFRi treatment sug-
gests that PI3K and MEK branches act in parallel. To
directly test the dual need for PI3K and MEK signaling,
we treated embryos with both inhibitors and observed a
dramatic loss of liver and lung markers similar to FGFRi
treatment (Figure 6B,C). Additionally, although many
MEKi + PI3Ki embryos died by stage NF42, some
remaining embryos exhibited severe foregut organ agen-
esis (Figure 6B). Treatment with PI3Ki, MEKi, or MEKi +
PI3Ki did not disrupt expression of hhex or pdx1 in the
embryos at stage NF35 (Figure 6B,C), with the exceptionof a modest decrease in the hhex expression area in PI3Ki
treated embryos similar to FGFRi (Additional file 3:
Figure S3B). The observation that combined MEK +
PI3Ki treatment did not expand pdx1 expression like the
FGFRi embryos suggests either that another pathway
downstream of FGFR represses pancreatic fate, and/or
that PI3K and MEK have additional FGF-independent
pro-pancreatic roles in the foregut (Figure 6B,C, Add-
itional file 3: Figure S3B).
We therefore examined the impact that FGF, PI3K,
and MEK inhibition had on proliferation and cell death.
Embryos treated with FGFRi, PI3Ki, or MEKi did not
exhibit significantly changed foregut cell proliferation
at stages NF23 or NF35 relative to vehicle treated con-
trols as measured by phospho-histone H3 (pHH3)
(Additional file 4: Figure S4A, B). However, at stage
NF42, when organ buds undergo extensive outgrowth
[55], FGFRi and PI3Ki embryos exhibited a significant
decrease in foregut cell proliferation (Additional file 4:
Figure S4A,B). Analysis of apoptosis by activated caspase-3
immunostaining demonstrated that PI3Ki (but not
FGFRi or MEKi) treatment increased foregut endo-
derm cell death at stage NF23 and NF35 (Additional
file 4: Figure S4C,D). The fact that PI3Ki causes
increased cell death, whereas the FGFRi did not sup-
ports the idea that additional FGF-independent PI3K-
mediated signaling pathway(s) promote foregut cell
survival.
Figure 6 Both PI3K and MEK signaling contribute to lung and liver development. (A) Western blot analysis of embryos cultured in DMSO,
PI3Ki (LY294002), or MEKi (U0126) from stages NF18 to NF35 in triplicate shows a dramatic decrease in pAkt and pErk levels with PI3Ki and MEKi
treatment respectively. (B) Embryos cultured in DMSO or the indicated inhibitors from NF18 to NF35 were analyzed at stage NF35 for liver
(nr1h5), lung (nkx2.1), pancreas (ptf1α), liver/thyroid (hhex), and pancreatic/duodenal (pdx1) expression. Embryos cultured in DMSO or the
indicated inhibitors from NF18 to NF35 were analyzed at stage NF42 for organ bud appearance with hnf4α-stained gut tubes. Yellow arrows
indicate normal expression, red arrows indicate reduced or absent expression. Foregut organ buds are outlined in dashed lines (lu; lung, p;
pancreas, lv; liver, s; stomach, i; intestine, th; thyroid, p/d; pancreas/duodenum). (C) Summary of the percentage of inhibited embryos with
expanded, normal, weak, or severely reduced/absent foregut marker expression compared to controls with the number of embryos analyzed
listed for each condition. FGFRi data is repeated from Figure 3 for comparison.
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of FGF signaling contribute to lung and liver specifica-
tion in Xenopus with the PI3K branch being particularly
important for lung. In addition FGFR and PI3K regulate
organ bud proliferation with FGF-independent PI3K ac-
tivity also promoting Xenopus foregut cell survival.
Discussion
The role of FGF signaling in Xenopus foregut organ de-
velopment has not been systematically examined to date.
In this study we show that:
1. The pancreas, liver and lung are specified at
progressively later times in development and that the
liver and lung require progressively longer
mesodermal contact between stages NF16-35;
2. Activated pErk, indicative of FGF signaling, is
detected in the developing foregut endoderm
throughout this period of development;
3. Prolonged FGF signaling via both the MEK and PI3K
pathways is required for Xenopus lung and liver
specification in vivo and this is at least in part a cell
autonomous requirement in the endoderm;
4. FGF signaling regulates the allocation of hhex + liver
progenitors versus pdx1+ pancreatic/duodenum
progenitors.
Horb and Slack have previously shown that contact
with the mesoderm between stages NF15-42 was essen-
tial for the endoderm to express liver and pancreas
genes at stage NF42 [26]. Our work extends this study
by examining if different lineages are specified at differ-
ent time points during development and tests the role of
FGF signaling in this process. Our data show that the
liver and lung lineages are specified at progressively later
times in development, requiring mesodermal contact for
increasingly longer times. The critical period of meso-
dermal contact between stages NF16-35 correlates with
the presence of pErk in the foregut endoderm and the
necessity for prolonged FGF signaling for the expression
of liver and lung, but not pancreas, specification mar-
kers. We demonstrated that specification of liver and
lung lineages requires mesoderm contact from stages
NF16-31 and NF16-35 respectively. Interestingly, we
found that as early as stage NF16-19 endoderm explants
without mesoderm were able to express pancreatic mar-
kers pdx1 and ptf1a at stage 35. This result contrasts
with those of Horb and Slack who found that the meso-
derm was required between stages NF25-42 for anterior
endoderm to express pdx1 at stage NF42 when organ
buds begin to form. This suggests that although we de-
tect pdx1 expression in endoderm explants cultured
without mesoderm at stage NF35, pancreatic fate might
not yet be stably committed; thus mesodermal contactcould be required through stage NF42 to maintain later
pancreatic gene expression. This is consistent with the
role of FGF/PI3K-mediated signaling promoting prolif-
eration of a pdx1+ cell population.
Our data suggest that the prolonged requirement for
the mesoderm in liver and lung specification can, at least
in part, be accounted for by prolonged FGF signaling.
Together with the recent report by Drysdale and collea-
gues who similarly found that FGF signaling was
required for Xenopus lung development [46], our data
demonstrate that the critical role for FGF signaling in
liver and lung is highly conserved in vertebrates [3,6-
10,56]. Our results are consistent with findings from
chick [7,57] and mouse [8,10,12] explant cultures show-
ing that mesodermal contact and FGF signaling are
required for the specification of liver and lung. In
addition, although the lateral plate mesoderm is clearly
patterned by FGFs [50], our results targeting the
dnFGFR to the foregut endoderm demonstrates a cell
autonomous requirement for active FGF signaling in
liver and lung development similar to endoderm-specific
transgenic analysis in mice [9]. It is worth noting that
while the molecular pathways are conserved between
different species the relative timing of lineage specifica-
tion is somewhat different. We show that liver and lung
fate is specified in Xenopus between the 30–37 somite
stages (ss), which is similar to zebrafish at 26–30 ss [58];
however in mouse and chick these fates are specified be-
tween the 7–10 ss [8,59]. We speculate that these differ-
ences could be influenced in part by the relatively early
heart development in amniotes.
In vitro mouse foregut explants studies suggest that
different doses of FGF segregate the foregut endoderm
into pancreas, liver and lung lineages with little or no
FGF being required for pancreas, intermediate FGF
doses promoting liver and high FGF concentration pro-
moting lung fate in the foregut explants [8]. Similarly
hhex expression in hepatoblasts is FGF-dependent in
zebrafish embryos [6] and chick explants [7]. Our results
are in general agreement with these studies; we also
found that FGF signaling promoted liver and lung and
repressed pancreas. However we did not find any evi-
dence supporting a dose requirement for liver versus
lung induction in Xenopus, although we cannot totally
rule out this mechanism. We also did not find discrete
short periods in development when liver versus lung fate
was induced. Rather our data support a duration model
where prolonged FGF signaling is required to specify
both liver and lung lineages, with the lung seeming to
require a longer duration of FGF activity. Different dura-
tions of FGF signaling are important in the development
of other systems as well, for instance, in lens epithelial
cells it has been shown that low doses of FGF signaling
(associated with a short duration of active pErk
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(associated with prolonged pErk signaling) promote fiber
differentiation [60].
We also postulate that the spatial requirement for FGF
signaling in vivo is also likely to be important factor in
regulating the duration of exposure to a FGF signal. We
observed that in some FGF inhibited embryos the re-
sidual liver gene (nr1h5) expression was immediately
next to the cardiac mesoderm, suggesting liver gene ex-
pression was only induced in the cells closest to a source
of FGF. It is important to point out that our experiments
do not formally demonstrate that the mesoderm alone is
the source of the FGF ligands; evidence from chick and
Xenopus embryos shows the endoderm also expresses
FGF ligands [7,52] and thus autocrine signaling within
the endoderm could be involved.
Our data indicate that both the MEK and PI3K
branches of the FGF response contribute to lung and
liver induction. Inhibition of either branch resulted in
intermediate phenotypes compared to FGFRi, while
combining MEKi and PI3Ki caused a dramatic loss of
mature liver and lung markers recapitulating the FGFRi
treatment. Our data also indicate that the PI3K activity
is important for cell survival and proliferation, and some
of this activity appears to be FGF-independent, consist-
ent with a report that pAkt signaling has an anti-
apoptotic role in Xenopus stomach/pancreas develop-
ment [29]. Our in vivo findings that both MEK and PI3K
are involved in liver and lung specification differ some-
what from explant studies of the mouse liver, where the
MEK branch is important for hepatic gene expression
while the PI3K branch is important for explant growth
[9].
We demonstrated that specification of liver and lung
lineages requires mesoderm contact from stages NF16-
31 and NF16-35 respectively and while our data suggest
that prolonged FGF signaling accounts for this in part, it
is likely that additional signals also differentially promote
these lineages at later stages. Indeed BMP, Wnt and Ret-
inoic acid are also required for foregut organogenesis
[6,7,11,25,48,61,62] and these probably interact with the
FGF pathway. Recent examples of such signaling cross
talk have come from studies in zebrafish suggest that
FGF signaling acts along the anterior-posterior axis to
restrict the competence of the endoderm to respond to
hepatic-inducing Wnt signals [13,14]. Consistent with
other signaling factors acting in concert with FGFs, we
found that exogenous FGF2 was not sufficient to sup-
port liver or lung fate in foregut explants lacking meso-
derm, whereas in vivo, and presumably in the presence
of other signals, activated caFGFR was sufficient to ex-
pand liver and lung at the expense of pancreas. This sug-
gests either that different FGF ligands are specifically
required for liver and lung induction and/or that othermesodermal signals are required to potentiate the indu-
cing activity of FGF2. Candidates for additional signals
include BMPs. It is also possible that the mesoderm pro-
vides important cell-cell or cell-ECM contacts that
might be necessary to support foregut organ cell fate. In-
deed, we have recently shown that fibronectin-
dependent BMP signaling is required to maintain foregut
progenitors [48]. In the future it will be important to
better understand the mechanisms by which the FGF
pathway interacts with other pathways during foregut
organogenesis.
Conclusions
The Xenopus embryo is increasingly being used to study
the development of endoderm derived organs, but the
molecular basis foregut lineage specification is poorly
understood. We demonstrate that the liver and lung
lineages are specified at progressively later times in de-
velopment requiring progressively longer mesoderm
contact between stages NF15-35. We show that FGF sig-
naling is active in the foregut endoderm at this time and
that lung and liver induction requires prolonged FGF
signaling through both the MEK and PI3K transduction
pathways. We conclude that FGF-mediated foregut
organ development in Xenopus is highly conserved with
that described in mammals. Moreover our results high-
light a previously unappreciated role for the temporal
regulation of signaling during organ induction, which
may impact strategies to direct the differentiation of
stem cells.
Additional files
Additional file 1: Figure S1. Exogenous FGF is not sufficient to induce
lung or liver lineages in explants. (A) Foregut explants with or without
mesoderm were cultured from stage NF18 to NF35 in BSA or FGF2 and
analyzed for expression of liver (nr1h5), lung (nkx2.1) and pancreas (pdx1)
markers. (B) Western blot analysis of explants shows an increase in pErk
levels upon FGF2 treatment.
Additional file 2: Figure S2. FGF signaling is not required for
maintaining foregut progenitors, but is required for lung and liver
induction in a dose-dependent manner. (A) Embryos cultured in DMSO
and FGFRi from stages NF15 to NF23 or injected with RNA encoding β-
gal (3 ng) or dnFGFR (3 ng) were analyzed for expression of the foregut
progenitor marker hhex and the cardiac progenitor marker nkx2.5. The
graph summarizes the percentage of embryos with normal, weak or
severely reduced/absent expression. (B) Embryos cultured from stages
NF18 to NF35 in DMSO or FGFRi at the indicated concentrations and the
percent of embryos with normal, weak, or severely reduced/absent nr1h5
and nkx2.1 expression was scored at stage NF35.
Additional file 3: Figure S3. Prolonged MEK and PI3K signaling are
required for a full lung and liver induction. (A) Percentage of embryos
treated with either; DMSO, FGFRi, PI3Ki or MEKi for the indicated stages
that exhibit with normal expression of nr1h5, nkx2.1, ptf1α, or tnni3
(n > 14 embryos for each condition and probe). Inhibition of MEK or PI3K
over various intermediate durations results in a reduction in specification
markers, suggesting that prolonged signaling is required for full foregut
organ gene expression. (B) Quantification of average hhex and pdx1
expression areas in control and inhibited embryos. ImageJ software was
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controls set to 1. Averages are based on n> 13 embryos for each
condition and marker from at least two independent experiments,
standard deviation and significance based on t-test (**p < .004) as
indicated. FGFRi data is repeated from Figure 3 for comparison.
Additional file 4: Figure S4. Cell Proliferation and apoptosis in FGF-
inhibited embryos. (A) Analysis of cell proliferation by phospho-histone
H3 (pHH3) immunostaining in embryos treated with DMSO, FGFRi, PI3Ki
or MEKi. At stages NF23 (mid-sagittal) and NF35 (transverse section)
embryos were assayed by 80 μM confocal Z-stack of pHH3
immunostaining (white dots), whereas stage NF42 isolated gut tubes
were assayed by pHH3 immunohistochemistry (blue dots). Yellow dashed
lines outline the foregut region quantified. (B) Summary of mean number
of pHH3+ cells in the foregut region +/− SD (n > 5 embryos for each
condition and stage). (C) Analysis of apoptosis by activated Caspase-3
immunostaining in embryos treated with DMSO, FGFRi, PI3Ki or MEKi. At
stages NF23 (mid-sagittal) and NF35 (transverse section) embryos were
assayed by 80 μM confocal Z-stack immunostaining (white dots). Yellow
dashed lines outline the foregut region quantified. (D) Summary of mean
number of active caspase-3+ cells in the foregut region +/− SD (n > 5
embryos for each condition and stage).
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